Allurion Technologies Inc. (ALUR)
USD 0.31
(-1.65%)
USD 0.31
(-1.65%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -78.07 Million USD | -143.92% |
| 2022 | -32.01 Million USD | -156.06% |
| 2021 | -12.5 Million USD | -241698.84% |
| 2020 | -5170.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -11.29 Million USD | 56.13% |
| 2024 Q2 | -9.24 Million USD | 18.1% |
| 2023 Q3 | -26.15 Million USD | -96.74% |
| 2023 FY | -78.07 Million USD | -143.92% |
| 2023 Q4 | -25.73 Million USD | 1.59% |
| 2023 Q2 | -13.29 Million USD | 4.3% |
| 2023 Q1 | -13.89 Million USD | -36.88% |
| 2022 Q2 | -4.29 Million USD | 23.12% |
| 2022 Q1 | -5.58 Million USD | -750.47% |
| 2022 Q4 | -10.14 Million USD | 15.33% |
| 2022 Q3 | -11.98 Million USD | -179.18% |
| 2022 FY | -32.01 Million USD | -156.06% |
| 2021 Q3 | -469.63 Thousand USD | 34.14% |
| 2021 Q4 | -656.58 Thousand USD | -39.81% |
| 2021 Q2 | -713.1 Thousand USD | -81.91% |
| 2021 Q1 | -392 Thousand USD | 0.0% |
| 2021 FY | -12.5 Million USD | -241698.84% |
| 2020 FY | -5170.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 101.205% |
| Artivion, Inc. | 5.74 Million USD | 1459.77% |
| Avanos Medical, Inc. | 4.2 Million USD | 1959.0% |
| Butterfly Network, Inc. | -145.61 Million USD | 46.379% |
| Butterfly Network, Inc. | -145.61 Million USD | 46.379% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | 120.344% |
| Boston Scientific Corporation | 2.34 Billion USD | 103.332% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | -414.28% |
| CONMED Corporation | 130.78 Million USD | 159.699% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | 105.089% |
| Paragon 28, Inc. | -37.3 Million USD | -109.274% |
| Glaukos Corporation | -128.7 Million USD | 39.333% |
| Globus Medical, Inc. | 133.14 Million USD | 158.643% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | -93.881% |
| Integer Holdings Corporation | 167.33 Million USD | 146.661% |
| Medtronic plc | 5.14 Billion USD | 101.518% |
| Nevro Corp. | -99.3 Million USD | 21.378% |
| Owlet, Inc. | -28.63 Million USD | -172.695% |
| Penumbra, Inc. | 73.55 Million USD | 206.155% |
| Vicarious Surgical Inc. | -80.66 Million USD | 3.208% |
| Smith & Nephew plc | 425 Million USD | 118.371% |
| Sonendo, Inc. | -57.74 Million USD | -35.216% |
| STERIS plc | 836.11 Million USD | 109.338% |
| Stryker Corporation | 3.88 Billion USD | 102.008% |
| Vapotherm, Inc. | -39.08 Million USD | -99.79% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | 106.111% |